Rovco has been awarded the site characterisation operations for the Green Volt floating offshore wind farm, situated 80 km east of Peterhead, Scotland. Slated to be fully operational by 2029, Green Volt is poised to become one of the world's largest floating offshore wind farms.

Oxford Drug Design, an Oxford-based AI drug discovery company and pioneer in AI therapeutic innovation, has appointed leading oncologist and academic Professor Sarah Blagden to its Scientific Advisory Board.

SeeChange Technologies, a company known for its retail-focused computer vision AI technology, has announced a strategic partnership with Diebold Nixdorf, a global leader in retail consumer and staff journey solutions, to introduce an innovative series of AI-powered self-checkout solutions.

Concr has initiated the recruitment of patients for the VISION trial, an observational clinical study designed to evaluate Concr's predictive algorithm that utilizes biomarkers to determine chemotherapy and immunotherapy responses in early-stage Triple Negative Breast Cancer (TNBC).

Cambridge Nutraceuticals, the parent company of science-backed nutritional food supplement brands, FutureYou Cambridge and Prime Fifty, has expanded its brand portfolio with the acquisition of GP Nutrition. GP Nutrition was founded by leading nutritionist and double Sunday Times bestselling author, Gabriela Peacock.

Biotech company Stemnovate is accelerating its research into rare mitochondrial diseases in children that severely impact the liver, heart and brain.

Sano Genetics will offer over 200 cost-free tests to individuals with a family history or a diagnosis of motor neurone disease (MND).

Albotherm Ltd, a UK based advanced materials startup, and leading Dutch horticultural coatings manufacturer Lumiforte announce their partnership to explore the integration of Lumiforte’s removable greenhouse coatings system with Albotherm’s patent pending, heat-activated shading technology.

Psyomics, a UK-based mental health technology company, has secured £4 million in fresh funding. Parkwalk Advisors (which invested in adsilico and Oxford Endovascular) the UK’s most active investor in university spinouts, led the funding round by investing a further £3.5 million.

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect®PLUS. In conjunction with the Company’s Cyto-Mine® platform, the new assay provides a streamlined method to measure antibody production in single cells by rapidly detecting secreted human IgG, enabling the identification and selection of cells with the highest productivity for more efficient cell line development.

DefiniGEN Ltd., and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to the US without freezing them thus preventing cell damage and loss-of function.

A new pilot undertaken by Cambridge crime busting company Featurespace and Pay.UK demonstrated unprecedented capability to save customers under attack from online fraudsters millions of pounds.